You are here

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

 

Online download statistics by month:

Online download statistics by month: June 2020 to March 2024

AbstractFullPdf
Jun 2020385385121
Jul 202026026085
Aug 202014414067
Sep 202013213293
Oct 2020787837
Nov 202010310369
Dec 2020979735
Jan 2021999949
Feb 202115915943
Mar 202116316347
Apr 202110010049
May 202110610659
Jun 202112012063
Jul 202112412468
Aug 202110110149
Sep 202113113168
Oct 202113613592
Nov 2021147147104
Dec 202114514787
Jan 202212212861
Feb 20229710165
Mar 202212813470
Apr 202211111753
May 202214714874
Jun 202218418564
Jul 202211512043
Aug 202212712882
Sep 202212612775
Oct 202213713764
Nov 202215615874
Dec 2022898946
Jan 2023898968
Feb 202313513540
Mar 202316016186
Apr 2023999943
May 202311711753
Jun 202312512554
Jul 202311611646
Aug 202311311739
Sep 202310710734
Oct 202310010041
Nov 202312412447
Dec 202312112259
Jan 202410710837
Feb 202410510736
Mar 202412612669
Total601360522808